A phase II randomized trial of nivolumab with stereotactic body radiotherapy (SBRT) versus nivolumab alone in metastatic (M1) head and neck squamous cell carcinoma (HNSCC) Meeting Abstract
| Authors: | McBride, S. M.; Sherman, E. J.; Tsai, C. J.; Baxi, S. S.; Aghalar, J.; Eng, J.; Zhi, W. I.; McFarland, D. C.; Michel, L. S.; Spielsinger, D.; Zhang, Z.; Flynn, J.; Dunn, L.; Ho, A. L.; Riaz, N.; Pfister, D. G.; Lee, N. Y. |
| Abstract Title: | A phase II randomized trial of nivolumab with stereotactic body radiotherapy (SBRT) versus nivolumab alone in metastatic (M1) head and neck squamous cell carcinoma (HNSCC) |
| Meeting Title: | 54th Annual Meeting of the American Society of Clinical Oncology (ASCO) |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 36 |
| Issue: | 15 Suppl. |
| Meeting Dates: | 2018 Jun 1-5 |
| Meeting Location: | Chicago, IL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2018-05-20 |
| Start Page: | 325s |
| Language: | English |
| ACCESSION: | WOS:000442916002302 |
| DOI: | 10.1200/JCO.2018.36.15_suppl.6009 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 6009 -- Source: Wos |
